Skip to main content
    S

    Serina Therapeutics Inc (SER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.36
    -0.05 (-3.87%)

    Market Cap: $37.73M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Serina Therapeutics Inc (SER) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Serina Therapeutics (SER) trades at 277.5x sales and 2.5x book value. Its P/S ranged from 147.2x in 2025 to 621.5x in 2024 across the 3 year ends with a P/S figure.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales277.5x
    Price to book2.5x
    PEGN/A
    FCF yield-65.8%
    As of Nov 17, 2026

    Valuation History

    Year endPriceP/SP/B
    2025$1.91147.2xN/A
    2024$5.01621.5x84.0x
    2023$13.75N/AN/A
    2022$19.71N/AN/A
    2021$38.93N/AN/A
    2020$54.29N/AN/A
    2019$65.00191.7x563.9x
    2018$106.79N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About SER

    What is SER's price to sales ratio?

    Serina Therapeutics has a price to sales ratio of 277.5x.